Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AdaptHealth (AHCO) Shares Outstanding (Weighted Average) (2017 - 2026)

AdaptHealth has reported Shares Outstanding (Weighted Average) over the past 9 years, most recently at $135.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 1.04% year-over-year to $135.1 million; the TTM value through Dec 2025 reached $135.1 million, up 1.04%, while the annual FY2025 figure was $135.1 million, 1.04% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $135.1 million at AdaptHealth, roughly flat from $135.3 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $135.3 million in Q3 2025 and troughed at $111.1 million in Q1 2021.
  • A 5-year average of $132.4 million and a median of $134.2 million in 2022 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 191.33% in 2021 and later dropped 1.2% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $126.3 million in 2021, then grew by 6.23% to $134.2 million in 2022, then fell by 0.01% to $134.2 million in 2023, then decreased by 0.3% to $133.8 million in 2024, then rose by 1.04% to $135.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for AHCO at $135.1 million in Q4 2025, $135.3 million in Q3 2025, and $134.9 million in Q2 2025.